Product Document Searching Made Easy by 2D Code! | TCI Materials Science News November 2025 | [TCIPracticalExample] Ullmann-type Coupling Reaction at Room Temperature... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 118081-37-1 | Product Number: C3391
Ceftibuten Hydrate
×
![]()
×
Purity: >95.0%(HPLC)
Synonyms:
- (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-4-carboxy-1-oxo-2-buten-1-yl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Hydrate
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 25MG |
$175.00
|
0 | 0 | Contact Us | |
| 100MG |
$520.00
|
4 | 0 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product has not been tested for potency and is guaranteed for chemical purity.
| Product Number | C3391 |
Purity / Analysis Method 
|
>95.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__5H__1__4N__4O__6S__2·xH__2O = 410.42 (as Anhydrous) |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Frozen (<0°C) |
| Condition to Avoid | Light Sensitive,Heat Sensitive |
| Packaging and Container
|
100MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 118081-37-1 |
| Related CAS RN
|
97519-39-6&118081-34-8&118081-35-9 |
| Reaxys Registry Number | 5892046 |
| PubChem Substance ID | 354335681 |
| Merck Index (14) | 1949 |
| MDL Number | MFCD00864918 |
Specifications
| Appearance | White to Light yellow to Light orange powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Specific rotation [a]20/D | +135 to +155 deg(C=0.6, pH 8 Phosphate buffer(calcd.on anh.substance)) |
| water | 8.0 to 13.0 % |
| NMR | confirm to structure |
Properties (reference)
| Specific Rotation | 143° (C=1,Phosphate buffer sol.) |
GHS
Related Laws:
| RTECS# | XI0367220 |
Transport Information:
| H.S.code* | 2941.90-000 |
Application
Ceftibuten: A Third-Generation β-Lactamase-Stable, Broad-Spectrum Cephalosporin
Ceftibuten (7432-s) is a third-generation cephalosporin that exhibits good antimicrobial activity against many Gram-negative and some Gram-positive organisms. Ceftibuten exerts its bactericidal action by binding to essential target proteins of the bacterial cell wall. This binding leads to inhibition of cell-wall synthesis. Especially, ceftibuten has a greater affinity for penicillin-binding protein 3 (PBP 3) more than other cephalosporins. Ceftibuten has a carboxyethylidene substituent at the 7 position, and thereby it is stable against both β-lactamases of Gram-negative bacteria and those mediated by R plasmids. (The product is for research purpose only.)
References
- Ceftibuten - in vitro activity against respiratory pathogens, β-lactamase stability and mechanism of action
- Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy
- Ceftibuten: An Overview
- Liquid chromatographic determination of ceftibuten, a new oral cephalosporin, in human plasma and urine
PubMed Literature
Documents
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.